Butyrate

The most biologically potent short-chain fatty acid (C4). Butyrate is the primary energy source for colonocytes, a histone deacetylase (HDAC) inhibitor with broad epigenetic effects, and a key anti-inflammatory mediator. Its depletion -- driven by loss of butyrate-producing bacteria under metal exposure, antibiotics, or poor diet -- is a near-universal feature of every disease covered in this wiki. For the full SCFA family, see short chain fatty acids.

Production

Butyrate is synthesized via the butyryl-CoA:acetate CoA-transferase pathway by obligate anaerobic bacteria:
- Roseburia (R. intestinalis, R. hominis): Major producers; enriched by dietary fiber and ketogenic diet in MS.
- faecalibacterium prausnitzii: The most abundant Firmicute in the healthy gut (~5% of total bacteria); its depletion is a hallmark biomarker of IBD.
- Coprococcus: Produces butyrate from lactate and acetate via cross-feeding.
- Eubacterium (E. rectale, E. hallii): Key cross-feeders that convert acetate and lactate to butyrate.
- blautia: Some species contribute via acetyl-CoA pathway.

Cross-feeding is essential: acetate produced by bifidobacterium is converted to butyrate by Roseburia and Faecalibacterium, linking these communities functionally.

Mechanisms of Action

Colonocyte Energy (70% of Energy)

Butyrate is oxidized via beta-oxidation in colonocytes, consuming oxygen and maintaining the hypoxic luminal environment necessary for obligate anaerobe survival (see hypoxic signaling). Without butyrate, colonocytes switch to glucose fermentation, oxygen diffuses into the lumen, and the resulting aerobic environment favors pathobiont expansion -- a self-reinforcing cycle of dysbiosis.

HDAC Inhibition

Butyrate inhibits class I and II histone deacetylases, broadly opening chromatin and altering gene expression:
- Foxp3 upregulation: Drives naive T cell differentiation into regulatory T cells (Tregs), suppressing autoimmunity and chronic inflammation.
- NF-kB suppression: Reduces macrophage production of TNF-alpha, IL-6, and IL-12.
- Tight junction induction: Upregulates claudins, occludin, and ZO-1 expression in epithelial cells.
- Anti-proliferative: Inhibits cancer cell growth and induces apoptosis -- the Warburg paradox (cancer cells ferment glucose rather than oxidize butyrate, so butyrate accumulates as an HDAC inhibitor).

GPR109A (HCAR2) Signaling

Butyrate activates GPR109A on colonocytes, macrophages, and dendritic cells:
- Promotes IL-10 production and Treg differentiation.
- Suppresses nf kappa b-mediated inflammatory signaling.
- Niacin (vitamin B3) is an alternative GPR109A ligand, partially explaining the anti-inflammatory effects of niacin supplementation.

Disease Relevance

Butyrate depletion is documented in:
- IBD: F. prausnitzii loss is both diagnostic and mechanistic; butyrate enemas show therapeutic benefit.
- Cardiovascular disease: Reduced butyrate production correlates with increased tmao and endotoxemia [luqman 2024 intestinal microbiome cvd intervention].
- Neurodegeneration: Butyrate modulates microglial activation; shifts microglia from M1 (pro-inflammatory) to M2 phenotype.
- ASD: Fecal butyrate reduced; correlates with GI symptoms and behavioral severity.
- Colorectal cancer: Butyrate's anti-proliferative effect is protective; its loss removes a tumor suppressor.
- MS: Ketogenic diet enriches propionate/butyrate producers correlated with reduced MRI lesions.

Metal Connections

Heavy metals (Cd, Pb, Hg, As, Ni) selectively eliminate butyrate-producing bacteria because these are obligate anaerobes lacking the metal efflux pumps and biofilm defenses of pathobionts. The resulting butyrate deficit:
1. Starves colonocytes, breaking the gut barrier.
2. Removes HDAC-mediated anti-inflammatory tone.
3. Shifts the luminal environment from anaerobic to aerobic, favoring Enterobacteriaceae.
4. Increases metal absorption through the damaged barrier, amplifying the cycle.